Abstract
In the last 30 years, tremendous progress in identifying transfusion‐transmitted viruses such as HBV, HCV, and HIV in industrialized countries has been achieved. Currently, the residual risk of transmitting these viruses through transfusion is very low especially after the introduction of “minipool” nucleic acid‐amplification tests. Despite these major technical advances, there remains a legitimate concern as to the transmission of other blood‐borne infectious agents through blood transfusion. Among these agents are HBV mutants, occult HBV, and HCV infections, malaria, Chagas, West Nile, dengue, and vesiviruses, bacterial infections such as Yersinia enterocolitica, and tick borne diseases such as human monocytic ehrlichiosis, human granulocytic ehrlichiosis, Rocky Mountain spotted fever, and Lyme and prion diseases such as Creutzfeldt and variant Creutzfeldt. Most of these agents are very rarely transmitted by transfusion in industrialized countries. However, an awareness of their possible transmission is essential for the control of spread of these diseases among the public by human‐to‐human transmission via blood transfusion. This review summarizes the current status of prevalence and diagnosis of these emerging diseases and also updates our knowledge on recently discovered non‐pathogenic blood‐borne viruses such as GB virus C and Torque Tenoviruses. J. Med. Virol. 79: 1229–1237, 2007. © 2007 Wiley‐Liss, Inc.